Thursday, May 30, 2019

Natco Pharma settles patent litigation with Onyx Therapeutics over cancer drug

Natco Pharma settles patent litigation with Onyx Therapeutics over cancer drug The company said it has reached a settlement agreement with Onyx Therapeutics Inc related to generic versions of 10mg, 30mg and 60mg of Kyprolis.

from Moneycontrol Business News http://bit.ly/2Kc0mlT

No comments:

Post a Comment

Small and midcap stocks may face volatility, but long-term returns still strong: Vikas Khemani

​Every day there was some negative news flow, global concern, geopolitical concern, inflation concern, oil prices, commodity, everything was...